AVTE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $4,592,352.10

Aerovate Therapeutics Insider Trading History Chart

Aerovate Therapeutics Share Price & Price History

^$21.67

▲ +0.59 (2.80%)

As of 03/23/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Aerovate Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/6/2023	Benjamin T. Dake	insider	Sell	10,282	$23.73	$243,991.86	1,609
3/1/2023	Timothy P. Noyes	CEO	Sell	15,000	$23.81	$357,150.00
2/6/2023	Benjamin T. Dake	insider	Sell	10,284	$24.59	$252,883.56	1,609
2/1/2023	Timothy P. Noyes	CEO	Sell	15,000	$22.68	$340,200.00
1/6/2023	Benjamin T. Dake	insider	Sell	10,284	$25.98	$267,178.32	1,609
1/3/2023	Timothy P. Noyes	CEO	Sell	15,000	$27.07	$406,050.00
12/12/2022	George A Eldridge	Insider	Sell	10,000	$30.04	$300,400.00	1,960
12/8/2022	George A Eldridge	Insider	Sell	12,011	$23.87	$286,702.57	1,960
12/5/2022	Ralph Niven	Insider	Sell	2,250	$17.38	$39,105.00	1,609
12/1/2022	Timothy P. Noyes	CEO	Sell	15,000	$18.00	$270,000.00
11/30/2022	George A Eldridge	Insider	Sell	85	$19.06	$1,620.10	1,960
11/23/2022	George A Eldridge	Insider	Sell	1,261	$19.07	$24,047.27	1,960
11/21/2022	George A Eldridge	Insider	Sell	2	$19.00	$38.00	1,960
11/18/2022	George A Eldridge	Insider	Sell	861	$19.52	$16,806.72	1,960
11/11/2022	Benjamin T. Dake	insider	Sell	6,198	$20.69	$128,236.62
11/8/2022	Benjamin T. Dake	insider	Sell	8,373	$18.09	$151,467.57	1,609
11/2/2022	Marinus Verwijs	SVP	Sell	1,130	$18.89	$21,345.70
11/1/2022	Timothy P. Noyes	CEO	Sell	1,038	$19.50	$20,241.00
10/17/2022	Benjamin T. Dake	insider	Sell	4,185	$20.16	$84,369.60
10/14/2022	Benjamin T. Dake	insider	Sell	110	$20.05	$2,205.50
10/10/2022	Benjamin T. Dake	insider	Sell	4,954	$16.89	$83,673.06
10/7/2022	Benjamin T. Dake	insider	Sell	10,520	$16.01	$168,425.20
10/5/2022	Ralph Niven	Insider	Sell	2,250	$15.75	$35,437.50	1,609
9/12/2022	Benjamin T. Dake	insider	Sell	7,520	$17.33	$130,321.60
9/8/2022	Benjamin T. Dake	insider	Sell	3,120	$18.20	$56,784.00
9/6/2022	Benjamin T. Dake	insider	Sell	9,166	$18.53	$169,845.98
8/18/2022	Ralph Niven	Insider	Sell	2,250	$21.18	$47,655.00	1,609
8/16/2022	Benjamin T. Dake	insider	Sell	21,000	$23.00	$483,000.00
8/11/2022	Benjamin T. Dake	insider	Sell	1,347	$23.93	$32,233.71
8/8/2022	Benjamin T. Dake	insider	Sell	6,943	$24.62	$170,936.66

Big Potential, Tiny Penny Stock

From Health Sector Insight | Ad

Little-known stock ready to disrupt the $4.37 trillion wellness market

Click here to download the full report.

SEC Filings (Institutional Ownership Changes) for Aerovate Therapeutics (NASDAQ:AVTE)

Institutional Buying and Selling by Quarter

Aerovate Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/23/2023	MetLife Investment Management LLC	5,228	$0.15M	0.0%	N/A	0.021%
2/15/2023	MetLife Investment Management LLC	5,228	$0.15M	0.0%	N/A	0.021%
2/15/2023	Trustees of Columbia University in the City of New York	13,190	$0.39M	0.8%	N/A	0.054%
2/15/2023	Silverarc Capital Management LLC	36,906	$1.08M	0.3%	N/A	0.151%
2/15/2023	State of Wisconsin Investment Board	8,567	$0.25M	0.0%	N/A	0.035%
2/15/2023	Soleus Capital Management L.P.	217,119	$6.36M	0.9%	N/A	0.889%
2/15/2023	Legal & General Group Plc	3,235	$95K	0.0%	+318.0%	0.013%
2/15/2023	Millennium Management LLC	123,208	$3.61M	0.0%	+47.3%	0.505%
2/15/2023	Morgan Stanley	2,190	$64K	0.0%	-54.0%	0.009%
2/15/2023	Eversept Partners LP	91,252	$2.67M	0.2%	N/A	0.374%
2/15/2023	Fred Alger Management LLC	147,955	$4.34M	0.0%	-18.8%	0.606%
2/15/2023	Alps Advisors Inc.	16,685	$0.49M	0.0%	N/A	0.068%
2/15/2023	Atlas Venture Life Science Advisors LLC	2,017,521	$59.11M	7.1%	-13.3%	8.265%
2/15/2023	Boothbay Fund Management LLC	25,813	$0.76M	0.0%	-27.8%	0.106%
2/15/2023	Nantahala Capital Management LLC	15,700	$0.46M	0.0%	N/A	0.064%
2/14/2023	Point72 Asset Management L.P.	175,022	$5.13M	0.0%	N/A	0.717%
2/14/2023	VR Adviser LLC	747,869	$21.91M	3.5%	-10.3%	3.064%
2/14/2023	Price T Rowe Associates Inc. MD	13,225	$0.39M	0.0%	N/A	0.054%
2/14/2023	Parkwood LLC	20,560	$0.60M	0.1%	-3.7%	0.084%
2/14/2023	Two Sigma Investments LP	21,137	$0.62M	0.0%	N/A	0.087%
2/13/2023	Charles Schwab Investment Management Inc.	24,641	$0.72M	0.0%	+3.7%	0.101%
2/13/2023	Barclays PLC	3,870	$0.11M	0.0%	+894.9%	0.016%
2/13/2023	Renaissance Technologies LLC	18,100	$0.53M	0.0%	N/A	0.074%
2/13/2023	Credit Suisse AG	9,071	$0.27M	0.0%	+18,042.0%	0.037%
2/13/2023	Geode Capital Management LLC	178,596	$5.23M	0.0%	+5.3%	0.732%
2/13/2023	JPMorgan Chase & Co.	5,267	$0.15M	0.0%	-22.8%	0.022%
2/10/2023	Bank of America Corp DE	7,556	$0.22M	0.0%	-40.6%	0.031%
2/10/2023	Cheyne Capital Management UK LLP	18,927	$0.56M	1.0%	N/A	0.078%
2/8/2023	Skandinaviska Enskilda Banken AB publ	53,340	$1.56M	0.0%	-5.5%	0.219%
2/8/2023	Swiss National Bank	20,701	$0.61M	0.0%	N/A	0.085%
12/8/2022	Bank of New York Mellon Corp	27,546	$0.46M	0.0%	+9.9%	0.113%
11/16/2022	Fred Alger Management LLC	182,281	$3.02M	0.0%	+5.5%	0.747%
11/16/2022	BNP Paribas Arbitrage SNC	3,962	$66K	0.0%	N/A	0.016%
11/15/2022	State Street Corp	173,178	$2.87M	0.0%	-3.0%	0.709%
11/15/2022	TCG Crossover Management LLC	959,572	$15.91M	4.8%	+7.9%	3.931%
11/15/2022	Vanguard Group Inc.	466,232	$7.73M	0.0%	+5.4%	1.910%
11/15/2022	Bank of New York Mellon Corp	27,546	$0.46M	0.0%	+9.9%	0.113%
11/15/2022	BlackRock Inc.	715,445	$11.86M	0.0%	+1.4%	2.931%
11/15/2022	Citadel Advisors LLC	1,615,578	$26.79M	0.0%	+1.5%	6.619%
11/14/2022	Lynx1 Capital Management LP	276,447	$4.58M	4.1%	+44.3%	1.133%
11/14/2022	Cormorant Asset Management LP	2,330,691	$38.64M	2.7%	+34.7%	9.548%
11/14/2022	Boothbay Fund Management LLC	35,757	$0.59M	0.0%	N/A	0.146%
11/14/2022	Ergoteles LLC	10,574	$0.18M	0.0%	-41.3%	0.043%
11/14/2022	Nuveen Asset Management LLC	34,976	$0.58M	0.0%	-9.8%	0.143%
11/14/2022	VR Adviser LLC	833,927	$13.83M	2.0%	+41.2%	3.416%
11/14/2022	Parkwood LLC	21,344	$0.35M	0.1%	-34.2%	0.087%
11/14/2022	Altium Capital Management LP	51,000	$0.85M	0.3%	N/A	0.209%
11/14/2022	Ghost Tree Capital LLC	150,000	$2.49M	0.7%	N/A	0.615%
11/10/2022	Tower Research Capital LLC TRC	3,449	$57K	0.0%	+569.7%	0.014%
11/10/2022	UBS Group AG	1,612	$26K	0.0%	N/A	0.007%
11/9/2022	Atlas Venture Life Science Advisors LLC	2,327,909	$38.60M	4.3%	-11.8%	9.537%
11/8/2022	New York State Common Retirement Fund	7,686	$0.13M	0.0%	+48.2%	0.031%
8/16/2022	Jane Street Group LLC	11,717	$0.18M	0.0%	N/A	0.048%
8/16/2022	Parkwood LLC	32,414	$32K	0.1%	N/A	0.133%
8/15/2022	State Street Corp	178,554	$2.79M	0.0%	+6.3%	0.731%
8/15/2022	Citadel Advisors LLC	1,592,009	$24.88M	0.0%	-0.1%	6.522%
8/15/2022	Millennium Management LLC	24,066	$0.38M	0.0%	N/A	0.099%
8/13/2022	American International Group Inc.	4,297	$67K	0.0%	-33.8%	0.018%
8/12/2022	Northern Trust Corp	76,140	$1.19M	0.0%	-27.1%	0.312%
8/12/2022	FMR LLC	634,766	$9.92M	0.0%	-11.8%	2.600%
8/12/2022	Rhumbline Advisers	13,193	$0.21M	0.0%	N/A	0.054%
8/11/2022	JPMorgan Chase & Co.	5,876	$92K	0.0%	-34.8%	0.024%
8/4/2022	Chicago Partners Investment Group LLC	10,163	$0.23M	0.0%	N/A	0.042%
8/3/2022	Atlas Venture Life Science Advisors LLC	2,638,297	$41.24M	6.9%	-15.0%	10.808%
7/29/2022	Russell Investments Group Ltd.	2,056	$32K	0.0%	N/A	0.008%
6/30/2022	Amalgamated Bank	1,462	$27K	0.0%	N/A	0.006%
6/7/2022	Bank of America Corp DE	4,103	$75K	0.0%	-56.9%	0.017%
5/18/2022	Golden State Equity Partners	20,980	$0.39M	0.2%	+31.7%	0.086%
5/16/2022	State Street Corp	168,037	$3.08M	0.0%	+9.0%	0.688%
5/13/2022	Northern Trust Corp	104,450	$1.92M	0.0%	+19.8%	0.428%
5/13/2022	Charles Schwab Investment Management Inc.	32,853	$0.60M	0.0%	+32.8%	0.135%
5/13/2022	American International Group Inc.	6,494	$0.12M	0.0%	+21.3%	0.027%
5/13/2022	Vanguard Group Inc.	480,110	$8.80M	0.0%	+2.5%	1.967%
5/12/2022	BlackRock Inc.	746,934	$13.69M	0.0%	+2.3%	3.060%
5/12/2022	Penn Mutual Asset Management LLC	17,458	$0.32M	0.4%	N/A	0.072%
5/12/2022	Citigroup Inc.	1,420	$26K	0.0%	-59.1%	0.006%
5/11/2022	Bank of New York Mellon Corp	30,487	$0.56M	0.0%	+28.0%	0.125%
5/11/2022	Skandinaviska Enskilda Banken AB publ	14,108	$0.26M	0.0%	N/A	0.058%
5/11/2022	JPMorgan Chase & Co.	9,007	$0.17M	0.0%	+49.8%	0.037%
5/10/2022	Sectoral Asset Management Inc.	218,913	$4.01M	0.7%	-22.6%	0.897%
5/5/2022	New York State Common Retirement Fund	12,591	$0.23M	0.0%	+164.0%	0.052%
2/18/2022	TCG Crossover Management LLC	853,330	$10.06M	4.7%	N/A	3.496%
2/14/2022	Citadel Advisors LLC	1,597,479	$18.84M	0.0%	+0.2%	6.544%
2/11/2022	Parkwood LLC	37,156	$0.44M	0.1%	-22.7%	0.152%
2/3/2022	OUP Management Co. LLC	603,762	$7.12M	3.2%	N/A	2.473%
2/2/2022	New York State Common Retirement Fund	4,770	$56K	0.0%	+165.0%	0.020%
11/16/2021	Citadel Advisors LLC	1,594,813	$32.41M	0.0%	-1.2%	6.533%
11/15/2021	Point72 Asset Management L.P.	53,872	$1.13M	0.0%	N/A	0.221%
11/15/2021	Sectoral Asset Management Inc	341,367	$7.16M	0.6%	-31.7%	1.398%
11/12/2021	Geode Capital Management LLC	114,423	$2.40M	0.0%	N/A	0.469%
11/9/2021	BlackRock Inc.	483,018	$10.13M	0.0%	N/A	1.979%
11/4/2021	Deutsche Bank AG	5,794	$0.12M	0.0%	N/A	0.024%
11/2/2021	New York State Common Retirement Fund	1,800	$38K	0.0%	N/A	0.007%
10/22/2021	Strs Ohio	2,300	$48K	0.0%	N/A	0.009%
8/17/2021	Millennium Management LLC	65,043	$1.49M	0.0%	N/A	0.281%
8/17/2021	Citadel Advisors LLC	1,614,998	$35.47M	0.0%	N/A	6.989%
8/16/2021	Squarepoint Ops LLC	9,000	$0.21M	0.0%	N/A	0.039%
8/16/2021	RA Capital Management L.P.	8,263,982	$188.67M	3.0%	N/A	35.762%
8/16/2021	Maven Securities LTD	9,854	$0.23M	0.0%	N/A	0.043%
8/16/2021	Goldman Sachs Group Inc.	104,755	$2.39M	0.0%	N/A	0.453%

Data available starting January 2016

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $21.67

$20.41

$21.67

50 Day Range

MA: $23.92

$19.99

$27.70

52 Week Range

Now: $21.67

$10.52

$30.79

Volume

45,432 shs

Average Volume

100,197 shs

Market Capitalization

$528.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of Aerovate Therapeutics?: Aerovate Therapeutics' top insider shareholders include:
George A Eldridge (Insider)
Benjamin T Dake (Insider)
Ralph Niven (Insider)
Cormorant Asset Management, Lp (Insider)
Marinus Verwijs (SVP)
Timothy P Noyes (CEO)
Learn More about top insider investors at Aerovate Therapeutics.
Who are the major institutional investors of Aerovate Therapeutics?: Aerovate Therapeutics' top institutional shareholders include:
Atlas Venture Life Science Advisors LLC — 8.27%
VR Adviser LLC — 3.06%
Soleus Capital Management L.P. — 0.89%
Geode Capital Management LLC — 0.73%
Point72 Asset Management L.P. — 0.72%
Fred Alger Management LLC — 0.61%
Learn More about top institutional investors of Aerovate Therapeutics stock.
Which major investors are selling Aerovate Therapeutics stock?: Within the previous quarter, AVTE stock was sold by these institutional investors:
Atlas Venture Life Science Advisors LLC
VR Adviser LLC
Fred Alger Management LLC
Boothbay Fund Management LLC
Bank of America Corp DE
Skandinaviska Enskilda Banken AB publ
Morgan Stanley
JPMorgan Chase & Co.
During the previous year, company insiders that have sold Aerovate Therapeutics company stock include:
George A Eldridge (Insider)
Benjamin T Dake (Insider)
Ralph Niven (Insider)
Cormorant Asset Management, Lp (Insider)
Marinus Verwijs (SVP)
Learn More investors selling Aerovate Therapeutics stock.
Which major investors are buying Aerovate Therapeutics stock?: During the previous quarter, AVTE stock was acquired by institutional investors including:
Soleus Capital Management L.P.
Point72 Asset Management L.P.
Eversept Partners LP
Millennium Management LLC
Silverarc Capital Management LLC
Two Sigma Investments LP
Swiss National Bank
Cheyne Capital Management UK LLP